In silico design of novel pyridazine derivatives as balanced multifunctional agents against Alzheimer’s disease
Abstract Alzheimer’s disease (AD) necessitates innovative therapeutic approaches that target its multifaceted pathology. This study investigates a series of 2-aminoalkyl-6-(2-hydroxyphenyl)pyridazin-3(2H)-one derivatives as potential multi-target ligands for AD, aiming to simultaneously inhibit acet...
Saved in:
| Main Authors: | Mourad Aloui, Mohamed El fadili, Somdutt Mujwar, Mohammed Er-rajy, Hatem A. Abuelizz, Sara Er-rahmani, Sara Zarougui, Elhalaoui Menana |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-98182-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In silico design of novel dihydropteridone derivatives with oxadiazoles as potent inhibitors of MCF-7 breast cancer cells
by: Mourad Aloui, et al.
Published: (2025-07-01) -
Design and evaluation of novel triazole derivatives as potential anti-gout inhibitors: a comprehensive molecular modeling study
by: Mohammed Er-rajy, et al.
Published: (2025-03-01) -
Design of novel pyrazole and benzofuran-based derivatives as potent acetylcholinesterase inhibitors for Alzheimer’s disease management
by: Mohamed El Fadili, et al.
Published: (2025-05-01) -
The potential of Curcuma longa L. bioactive compounds as RSK inhibitors for the treatment of prostate cancer: in silico study
by: Olusola Olalekan Elekofehinti, et al.
Published: (2025-01-01) -
Pyridazine Based Compounds with PARP-1 Inhibitory Activity
by: Norhan A. Abdelrahman, et al.
Published: (2023-12-01)